Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s

June 8, 2026

More like this

August 19, 2026

Developer raises $36M, will help fund late-stage Parkinson’s clinical trial

Parkinson's News Today

August 13, 2026

Remepy raises US$36m to advance Parkinson’s treatment into Phase III

Health Tech World

August 12, 2026

Remepy Raises $36 Million Series A To Advance Hybridopa Phase III And Hybrid Drug Pipeline

Pulse 2.0